PB2294: DOSE-ADJUSTED EDOCH AS FIRST-LINE THERAPY IMPROVED PROGNOSIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA: A 11-YEAR MULTICENTER RETROSPECTIVE STUDY IN CHINA

oleh: Luting Luo, Jiazheng LI, Wanying Liu, Yanxin Chen, Zhengjun Wu, Chengjun Nie, Xiaoyun Zheng, Renli Chen, Ting Yang, Jianda Hu

Format: Article
Diterbitkan: Wiley 2023-08-01

Deskripsi

No description available for this item.